Primary Progressive Multiple Sclerosis Evolving from Radiologically Isolated Syndrome

Annals of Neurology

Volumn 79, Issue 2, 2016, Pages 288-294

  Kantarci, Orhun H ^a   Lebrun, Christine ^b   Siva, Aksel ^c   Keegan, Mark B ^a   Azevedo, Christina J ^d   Inglese, Matilde ^e   Tintoré, Mar ^f   Newton, Braeden D ^g   Durand Dubief, Francoise ^h   Amato, Maria Pia ⁱ   De Stefano, Nicola ^j   Sormani, Maria Pia ^k   Pelletier, Daniel ^d   Okuda, Darin T ^g  

^a MAYO CLINIC   (United States)

^b PASTEUR HOSPITAL   (France)

^c ISTANBUL UNIVERSITY   (Turkey)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h HÔPITAL NEUROLOGIQUE   (France)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j UNIVERSITY OF SIENA   (Italy)

^k UNIVERSITY OF GENOA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CLINICAL FEATURE; DEMOGRAPHY; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; RADIOLOGICALLY ISOLATED SYNDROME; RECURRENT DISEASE; SPINAL CORD LESION; ADOLESCENT; AGE; CHILD; CLINICAL TRIAL; DEMYELINATING DISEASES; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOLOGY; SEX DIFFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SEX FACTORS; YOUNG ADULT;

EID: 84958106126     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24564     Document Type: Article

References (26)

1. McDonald WI, Compston A, Edan G, et al., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 Jul; 50 (1): 121-7.
2. Polman CH, Reingold SC, Edan G, et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".[see comment]. Annals of Neurology. 2005; 58 (6): 840-6.
3. Polman CH, Reingold SC, Banwell B, et al., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb; 69 (2): 292-302.
4. Lublin FD,. New multiple sclerosis phenotypic classification. European Neurology. 2014; 72 Suppl 1: 1-5.
5. Barkhof F, Filippi M, Miller DH, et al., Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain: a journal of neurology. 1997 Nov; 120 (Pt 11): 2059-69.
6. Tintore M, Rovira A, Martinez MJ, et al., Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol. 2000 Apr; 21 (4): 702-6.
7. Okuda DT, Mowry EM, Beheshtian A, et al., Incidental MRI anomalies suggestive of multiple sclerosis. The radiologically isolated syndrome. Neurology. 2009; 72: 800-805.
8. Lebrun C, Bensa C, Debouverie M, et al., Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry. 2008 Feb; 79 (2): 195-8.
9. Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH,. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Multiple Sclerosis. 2009 Aug; 15 (8): 918-27.
10. Okuda DT, Siva A, Kantarci O, et al., Radiologically isolated syndrome: 5-year risk for an initial clinical event. PloS one. 2014; 9 (3): e90509.
11. Lublin FD, Reingold SC,. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 Apr; 46 (4): 907-11.
12. Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC,. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain. 2006 Mar; 129 (Pt 3): 584-94.
13. Kantarci O, Siva A, Eraksoy M, et al., Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology. 1998 Sep; 51 (3): 765-72.
14. Tutuncu M, Tang J, Zeid NA, et al., Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Multiple Sclerosis. 2013 Feb; 19 (2): 188-98.
15. Thompson A,. Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis. Mult Scler. 2004 Jun; 10 Suppl 1: S2-S7.
16. Confavreux C, Vukusic S,. Natural history of multiple sclerosis: a unifying concept. Brain. 2006 Mar; 129 (Pt 3): 606-16.
17. Koch M, Mostert J, Heersema D, De Keyser J,. Progression in multiple sclerosis: further evidence of an age dependent process. J Neurol Sci. 2007 Apr 15; 255 (1-2): 35-41.
18. Siva A, Radhakrishnan K, Kurland LT, et al., Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology. 1993 Oct; 43 (10): 1878-82.
19. Pittock SJ, McClelland RL, Mayr WT, et al., Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol. 2004 Aug; 56 (2): 303-6.
20. Paz Soldan MM, Novotna M, Abou Zeid N, et al., Relapses and disability accumulation in progressive multiple sclerosis. Neurology. 2015 Jan 6; 84 (1): 81-8.
21. McDonnell GV, Cabrera-Gomez J, Calne DB, Li DK, Oger J,. Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years. Mult Scler. 2003 Mar; 9 (2): 204-9.
22. Thompson AJ, Kermode AG, Wicks D, et al., Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol. 1991 Jan; 29 (1): 53-62.
23. Mori F, Rossi S, Piccinin S, et al., Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis. J Neurosci. 2013 Dec 4; 33 (49): 19112-9.
24. Campbell GR, Worrall JT, Mahad DJ,. The central role of mitochondria in axonal degeneration in multiple sclerosis. Multiple sclerosis. 2014 Dec; 20 (14): 1806-13.
25. Westlye LT, Walhovd KB, Dale AM, et al., Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. Cereb Cortex. Sep; 20 (9): 2055-68.
26. Hasan KM, Kamali A, Abid H, Kramer LA, Fletcher JM, Ewing-Cobbs L,. Quantification of the spatiotemporal microstructural organization of the human brain association, projection and commissural pathways across the lifespan using diffusion tensor tractography. Brain structure & function. May; 214 (4): 361-73.